Topic: AM PHARMA
222 results were found.
Japan's Kobayashi Pharmaceutical factory inspected amid supplement health scare - March 30, 2024
AstraZeneca to buy Amolyt Pharma - March 19, 2024
AstraZeneca to acquire Amolyt Pharma for $1.05 billion - March 14, 2024
Mark W. Womack named to Bridgewest Perth Pharma board - March 6, 2024
Basilea Pharmaceutica acquires novel antibiotics program targeting multidrug-resistant gram-negative bacteria - January 16, 2024
Johnson & Johnson to buy Ambrx Biopharma in $2 billion deal - January 8, 2024
Amylyx Pharmaceuticals appoints Camille L. Bedrosian as chief medical officer - November 29, 2023
Federal Police investigates fraud against Brazilian Popular Pharmacy Program - September 27, 2023
D&A Pharma calls France to use Alcover although European Medicines Agency didn't give marketing authorisation - June 22, 2023
CDC concludes Maiden Pharmaceuticals cough syrups likely to blame for children's deaths in Gambia - March 3, 2023
Sarah Otten joins Medison Pharma as VP, GM Americas region - January 9, 2023
Italy's Chiesi buys Irish Amryt Pharma for $1.48 billion - January 9, 2023
Finnish pharmacies run out of iodine tablets amid potential nuclear event - October 14, 2022
Phathom Pharmaceuticals appoints James Toppe to board - September 27, 2022
AmerisourceBergen to buy Germany's PharmaLex for $1.3b - September 14, 2022
Victor Papamoniodis joins Medison Pharma as VP international markets - January 20, 2022
PharmaMar confirms in vitro activity of plitidepsin against several variants, including Delta and Omicron - January 12, 2022
PharmaMar signs licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan - November 11, 2021
Ampio Pharmaceuticals appoints three experienced executives - October 14, 2021
Piramal Pharma Solutions expanding in Michigan, creating 31 high-wage jobs - July 22, 2021
Cumberland Pharmaceuticals promotes John Hamm to director - May 20, 2021
Walmart and Sam's Club now administering walk-up COVID-19 vaccines at 5,100+ pharmacies - May 5, 2021
Spain: PharmaMar to begin Phase 3 trial of drug to treat COVID-19 - April 30, 2021
PharmaMar's drug reduces COVID-19 viral loads 99% - January 26, 2021
Bora Pharmaceuticals selects Mississauga for its North American headquarters, employ 400 - December 3, 2020
Parliament wants EU to tackle pharmaceutical pollution - September 18, 2020
Piramal Pharma Solutions to acquire solid oral dosage drug product facility in Sellersville, Pa. - June 22, 2020
EIB gives 24m euros to AM-Pharma - March 31, 2020
Eurofarma acquires Hypera Pharma assets in Latin America - March 20, 2020
Menlo Therapeutics and Foamix Pharmaceuticals complete merger - March 9, 2020
Takeda to divest select assets in Latin America to Hypera Pharma for $825 million - March 2, 2020
Vietnam's pharmaceutical import up 11.3 percent in 10 months - November 7, 2019
N.Y. attorney general: Sackler family transferred $1 billion from Purdue Pharma to Swiss accounts - September 14, 2019
Oklahoma: Johnson & Johnson are kingpin of pharmaceutical cartel - July 15, 2019
Heritage Pharmaceuticals to pay more than $7 million in criminal penalty and civil damages - June 1, 2019
Astellas Pharma and Amgen to pay US$125 million in US charity kickback probe - April 26, 2019
Amneal Pharmaceuticals Q2 GAAP net revenue up 59.2% - August 10, 2018
Camargo Pharmaceutical Services appoints Daniel S. Duffy as new CEO - May 3, 2018
Romania approves A&D Pharma takeover with conditions - April 24, 2018
West Pharmaceutical Services appoints Silji Abraham as SVP - February 27, 2018
Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2 billion - December 26, 2017
Synergy Pharmaceuticals appoints Troy Hamilton as CEO - December 20, 2017
Sunesis Pharmaceuticals appoints William Quinn as CFO - December 1, 2017
Peregrine Pharmaceuticals appoints Mark R. Bamforth to boards - October 20, 2017
AzurRx BioPharma appoints Vern Lee Schramm to board - October 17, 2017
Tetraphase Pharma appoints Kamalam Unninayar as CFO - October 17, 2017
AMAG Pharma appoints Tracy Palmer Berns as chief compliance officer - October 3, 2017
William Hornung joins Diffusion Pharma as chief business officer - August 24, 2017
After two-year investigation New Hampshire sues Purdue Pharma for opioid crisis - August 9, 2017
Foamix Pharmaceuticals names David Domzalski as CEO - June 30, 2017
Adamas Pharmaceuticals names Alfred G. Merriweather as CFO - June 29, 2017
Merrimack Pharma names Sergio Santillana as CMO - June 9, 2017
Dicerna Pharma names Ralf Rosskamp as CMO - June 9, 2017
BioCryst Pharmaceuticals appoints Robert A. Ingram as chairman - May 31, 2017
RXI Pharma names Gerrit Dispersyn chief development officer - April 19, 2017
Oramed Pharmaceuticals appoints Ronald Law as CSO - March 22, 2017
Arena Pharmaceuticals names Preston Klassen as EVP, CMO - March 21, 2017
Eagle Pharmaceuticals names Richard A. Edlin to board - March 17, 2017
AzurRx BioPharma adds Charles J Casamento to board - March 9, 2017
CTI BioPharma appoints Adam Craig as CEO - February 28, 2017
Colorado charges Havana, Alameda Pharmacy for alleged theft of millions - February 17, 2017
Bellicum Pharmaceuticals names Rick Fair as CEO - February 1, 2017
X4 Pharmaceuticals names Sudha Parasuraman as chief medical officer - January 24, 2017
Alnylam Pharma appoints Pushkal Garg as CMO - January 5, 2017
Agios Pharma names Ian Clark to board of directors - January 3, 2017
AMAG Pharmaceuticals appoints Brian Kelley to board - December 22, 2016
Eagle Pharmaceuticals names David Pernock chief commercial officer - December 21, 2016
Innate Pharma names Mondher Mahjoubi as chairman of executive board - December 21, 2016
PharmaMar names Pascal Besman as COO of PharmaMar U.S. - November 17, 2016
Cipher Pharmaceuticals names Stephen L. Lemieux interim CEO - November 14, 2016
Samsung's biopharma unit makes successful public debut - November 11, 2016
Dechra Pharmaceuticals names non-executive director - November 10, 2016
Mereo BioPharma Group names Richard CM Jones as CFO - November 8, 2016
X4 Pharmaceuticals names Nancy Lurker as chair of board - October 6, 2016
Kleo Pharmaceuticals names chief scientific officer - September 23, 2016
ACADIA Pharma names Todd Young EVP and CFO - August 26, 2016
Endo names Joseph Ciaffoni as president, U.S. branded pharmaceuticals - August 9, 2016
Quantum Pharma names CFO Chris Rigg acting CEO - August 3, 2016
CutisPharma names Steven Dinh as chief scientific officer - August 2, 2016
AMAG Pharmaceuticals appoints VP, market access & corporate accounts - July 14, 2016
Biogen names EVP, pharmaceutical operations & technology - June 22, 2016
OPKO names SVP, pharmaceutical marketing and market access - May 12, 2016
Arena Pharma appoints Amit D. Munshi as president and CEO - May 11, 2016
aTyr Pharma appoints SVP, product programs and planning - May 6, 2016
Eiger BioPharma names Debra Odink SVP of technical operations - May 5, 2016
Galena Biopharma names Mary Ann Gray to its board - April 27, 2016
AMAG Pharma appoints Edward Myles as CFO - April 12, 2016
AcelRx Pharmaceuticals names Howard B. Rosen permanent CEO - March 30, 2016
Sagent Pharmaceuticals names Sean Brynjelsen EVP - March 25, 2016
Synergy Pharmaceuticals names Marino Garcia as EVP - March 14, 2016
Momenta Pharmaceuticals names new board member - March 11, 2016
Paratek Pharmaceuticals names Kris Peterso as director - March 8, 2016
Hikma Pharmaceuticals names John J. Castellani as director - February 23, 2016
AMAG Pharmaceuticals Q4 total revenues $108.7 million - February 18, 2016
Agios Pharmaceuticals names chief commercial officer - February 9, 2016
Aoxing Pharmaceutical appoints James Chen as CFO - February 3, 2016
Vertice Pharma names Indranil Nandi as VP, research & development - January 26, 2016
CTI BioPharma names Matthew Perry to board of directors - January 15, 2016
Inotek Pharmaceuticals names Carsten Boess to board - January 13, 2016
AMAG Pharmaceuticals expects Q4 non-GAAP product revenue of $124 million - January 12, 2016
Kitov Pharma names Gil Ben-Menachem as VP, business development - January 11, 2016
Turing Pharmaceuticals names Ron Tilles interim CEO - December 21, 2015
Fennec Pharmaceuticals appoints Khalid Islam as chairman - December 10, 2015
Momenta Pharmaceuticals names Matthew P. Ottmer as COO - December 8, 2015
OticPharma names Keith A. Katkin as chairman of the board - December 1, 2015
InMed Pharmaceuticals appoints Adam Cutler to board - November 24, 2015
Purdue Pharma names Alan W. Dunton as senior vice president - November 23, 2015
NovaBay Pharma names chairman as interim president and CEO - November 20, 2015
Synergy Pharmaceuticals names Gary Sender EVP and CFO - November 17, 2015
OticPharma names Catherine C. Turkel as chief development officer - November 13, 2015
Galena Biopharma names Bijan Nejadnik EVP - November 2, 2015
CoLucid Pharma names Mark Corrigan to board - October 28, 2015
BioBlast Pharma names Theresa Stevens CCDO - October 12, 2015
DS Biopharma names Leopoldo Zambeletti as non-executive director - September 28, 2015
PDL BioPharma appoints Samuel R. Saks as director - September 17, 2015
Amgen to acquire privately-held Dezima Pharma - September 16, 2015
EUSA Pharma adds William W. Crouse to board - September 10, 2015
Cardiome Pharma adds Robert James Meyer to board - September 9, 2015
Array BioPharma names Patricia Henahan as CFO - September 9, 2015
Sucampo Pharma launches tender to acquire R-Tech Ueno in $278 million deal - August 27, 2015
AMAG Pharmaceuticals appoints Joseph Vittiglio as SVP - August 26, 2015
M Pharma names Matthew B. Lehman as president and CEO - August 20, 2015
Tivorsan Pharmaceuticals elects James E. Connolly as CEO - August 19, 2015
Spring Bank Pharma names Martin Driscoll as president and CEO - August 19, 2015
Aspen Pharmacare director Nobuhle Judith Dlamini to resign - August 14, 2015
Horizon Pharma names EVP, global orphan business and intl. operations - August 10, 2015
BioCryst Pharmaceuticals adds Robert A. Ingram to board - August 10, 2015
Allergan and Kythera Biopharmaceuticals amended their merger deal - August 6, 2015
CTI BioPharma names EVP and chief commercial officer - July 28, 2015
Inotek Pharmaceuticals names Cadmus Collins Rich vice president - July 24, 2015
Inotek Pharmaceuticals names Claudine Prowse as vice president - July 21, 2015
Valeant to acquire Amoun Pharmaceutical for $800 million - July 18, 2015
Horizon Pharma names Tina Ventura VP, investor relations - July 10, 2015
AMAG Pharmaceuticals to acquire Cord Blood Registry for $700 million - July 1, 2015
Cerulean Pharma names Stuart Arbuckle to board - June 30, 2015
Conatus Pharma appoints Mason M. Yamashita as vice president - June 23, 2015
AMAG Pharmaceuticals appoints Aaron Pelta VP, business development - June 11, 2015
Alnylam Pharma appoints David-Alexandre Gros as SVP - June 9, 2015
Purdue Pharma names Jean-Jacques Charhon CFO - June 2, 2015
Juniper Pharmaceuticals adds James A. Geraghty to board - May 29, 2015
CutisPharma names Neal Muni as CEO - May 20, 2015
Ritter Pharma names Matthew W. Foehr to its board - February 10, 2015
Kite Pharma expands and strengthens leadership team - February 4, 2015
Raptor Pharma names chief medical officer and CFO - January 8, 2015
Rigel Pharma chairman, CEO James Gower retires - November 25, 2014
Moberg Pharma names new general manager of U.S. business - November 21, 2014
Intellipharmaceutics names new CFO - November 19, 2014
Intercept Pharma names SVP, head of Europe - November 18, 2014
Hikma Pharmaceuticals names Pamela Kirby director - November 10, 2014
Pharmavite names Nitin Deshpande to role of CFO - November 6, 2014
PDL BioPharma Bolsters Management Team - October 7, 2014
Celator Pharma names Michael Dougherty chairman - September 4, 2014
Tokai Pharmaceuticals names VP - August 29, 2014
Galena Biopharma names president, CEO - August 22, 2014
Auxilium Pharma names Andrew Saik CFO - August 12, 2014
Oxford Pharmascience names director - July 17, 2014
Immune Pharma names Cameron Durrant independent director - July 15, 2014
Baxter names CFO for new biopharmaceutical spin-off - July 10, 2014
Tetraphase Pharma names director - June 30, 2014
Aerie Pharmaceuticals names VP, business development - June 23, 2014
AMAG Pharmaceuticals names SVP of business development and strategy - June 12, 2014
Pharmagen names CFO - June 11, 2014
Ampio Pharmaceuticals appoints Gregory A. Gould as CFO - June 6, 2014
Zosano Pharma names CFO - June 3, 2014
Synergy Pharma names SVP, drug development - May 30, 2014
Pharmagen names Boyd Relac COO - April 30, 2014
Gino Santini new chairman of AMAG Pharmaceuticals - April 17, 2014
Purdue Pharma names Mark Timney as CEO - January 28, 2014
Ra Pharmaceuticals names chief business officer - October 1, 2013
Shanghai Fudan-Zhangjiang Bio-Pharma appoints Lam Yiu Kin as director - August 26, 2013
Aerie Pharmaceuticals names president and COO - August 6, 2013
Endo names COO of Pharmaceuticals - July 23, 2013
Marvin Samson joins Antares Pharma board - May 24, 2013
Pharmaceutical Product Development names SVP, global quality and compliance - March 26, 2013
Sagent Pharmaceuticals appoints James M. Hussey as president - March 22, 2013
Array BioPharma names chief medical officer - March 22, 2013
Bassam Damaj president of Innovus Pharma - January 23, 2013
Valeant Pharmaceuticals names Laizer D. Kornwasser company group chairman - January 3, 2013
Pharmalink AB strengthens senior management team - October 29, 2012
AMRI promotes Steven R. Hagen to SVP, pharmaceutical development and manufacturing - October 23, 2012
Simcere Pharmaceutical Group names Hongquan Liu as CEO - September 14, 2012
FluoroPharma announces promotion of Tamara Rhein to CFO - August 23, 2012
Onyx Pharmaceuticals names John E. Osborn SVP, global corporate affairs - July 9, 2012
Silvia Taylor senior vice president at Sucampo Pharmaceuticals - June 29, 2012
AVI BioPharma names Chris Garabedian chief executive officer - December 14, 2010
Alnylam Pharmaceuticals adds Marsha H. Fanucci to the board - December 9, 2010
Catabasis Pharmaceuticals: Michael Ross named chairman - December 9, 2010
NGM Biopharmaceuticals: William J. Rieflin CEO and director - October 6, 2010
SCOLR Pharma names Carl Johnson as chairman - September 28, 2010
Alnylam Pharmaceuticals adds Steven M. Paul to the board - September 23, 2010
AAIPharma Services names Patrick Walsh CEO - September 14, 2010
Bausch + Lomb names Daniel M. Wechsler as global president, pharmaceuticals - September 13, 2010
Eusa Pharma appoints Stephen A. Stamp to its board of directors - September 1, 2010
Poniard Pharmaceuticals: Mike Jackson named Interim CFO - August 10, 2010
Berlin Pharmaceutical Industry: Amal Naj Chief new CEO and director - July 14, 2010
Amneal Pharmaceuticals appoints Shankar Hariharan as chief scientific officer - July 9, 2010
ARIAD Pharmaceuticals: Timothy P. Clackson president of R&D - June 24, 2010
Spectrum Pharmaceuticals: James E. Shields new chief commercial officer - June 23, 2010
NOXXON Pharma AG appoints Aram Mangasarian as chief business officer - May 18, 2010
Oramed Pharmaceuticals: Michael Berelowitz new director - May 18, 2010
AMAG Pharmaceuticals appoints Gary J. Zieziula as EVP and chief commercial officer - April 28, 2010
Patheon names Mark Kontny president of global pharmaceutical development services - April 15, 2010
K-V Pharmaceutical appoints Stephen A. Stamp as new CFO - April 13, 2010
Idenix Pharmaceuticals adds Tamar D. Howson to the board - March 31, 2010
Omthera Pharmaceuticals names George Horner as chairman - March 29, 2010
Tianyin Pharmaceutical appoints James Jiayuan Tong as CFO - March 29, 2010
Marc Kamin joins PharmaNet Development Group as vice president - March 18, 2010
Manhattan Pharmaceuticals acquires Ariston Pharmaceuticals, names new management - March 12, 2010
Kinex Pharmaceuticals named Rudolf Kwan as chief medical officer - February 25, 2010
Afferent Pharmaceuticals names Bruce G. McCarthy as CEO - January 26, 2010
Viamet Pharmaceuticals: William Moore chief scientific officer - January 11, 2010
LifeCycle Pharma: William J. Polvino new president and CEO - December 2, 2009
Alexion Pharmaceuticals appoints William R. Keller to the board - December 2, 2009
SkyePharma: Jeremy Scudamore to step down, Frank Condella non-executive chairman - November 18, 2009
Roger W. Anderson named chief pharmacy officer for US Oncology - October 2, 2009
Amylin Pharmaceuticals elects Paulo F. Costa chairman of the board - August 24, 2009
Antares Pharma elected Eamonn P. Hobbs to board of directors - August 12, 2009
Michel Lespinasse new chief operating officer of A&D Pharma Holdings N.V. - July 20, 2009
Pro-Pharmaceuticals names Gilbert S. Omenn to Scientific Advisory Board - July 14, 2009
Hollis-Eden Pharmaceuticals: James M. Frincke president and CEO - June 15, 2009
Pharmacyclics Announces Ahmed Hamdy as New Chief Medical Officer - March 17, 2009
DOR BioPharma Appoints Brian L. Hamilton as Chief Medical Officer - March 13, 2009